Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Clorox Co    CLX

Delayed Quote. Delayed  - 09/27 10:01:56 pm
125.84 USD   +0.12%
09/26 EVOLVE THIS : Clorox 2016 Integrated Annual Report Highlights Fiscal..
09/26 CLOROX HEALTHCA : Introduces the Next Generation of Bleach
09/20 BRITA : and University of California, Berkeley Team Up To Reduce Bot..
News SummaryMost relevantAll newsSector news 

The Clorox Company : Refutes Silent Spring Institute's Study on Our Consumer Products

share with twitter share with LinkedIn share with facebook
share via e-mail
03/08/2012 | 03:26pm CEST

We have reviewed the findings of Silent Spring's study claiming some U.S. consumer products contain endocrine-disrupting and asthma-related ingredients.

Product safety is a top priority at The Clorox Company and our company guidelines prohibit using endocrine-disrupting ingredients in our products. For those household products containing fragrance ingredients some consider to be asthma related, these ingredients are present at such low concentrations they do not cause irritation or trigger asthma when used as directed.

Our highly skilled scientists evaluate each product's safety, efficacy and regulatory compliance before it makes it to store shelves. Our safety assessments begin with analysis of each of the materials that go into making the product. This includes consideration of short-term and long-term impact from all types of exposures, including incidental or accidental, and routes of exposure such as skin, eye, ingestion and inhalation. Our safety evaluation also includes the assessment of fragrances, dyes, and preservatives, and other proprietary ingredients, in our formulations.

Clorox voluntarily discloses all ingredients for our U.S. and Canadian household cleaning and disinfecting products through our industry-leading initiative, Ingredients Inside (www.IngredientsInside.com), which is available on our corporate web site and mobile platforms.

For more information on our product stewardship guidelines, visit http://www.thecloroxcompany..

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on CLOROX CO
09/26 CLOROX HEALTHCARE : Introduces the Next Generation of Bleach
09/26 EVOLVE THIS : Clorox 2016 Integrated Annual Report Highlights Fiscal Year Progre..
09/20 BRITA : and University of California, Berkeley Team Up To Reduce Bottled Water W..
09/20 THE CLOROX COMPANY : Launches New Corporate Website
09/20 THE CLOROX COMPANY : Voluntarily Recalls Liquid Plumr® Pro-Strength Foaming Clog..
09/19DJCorrection to Koch Tries Hand at Carpet Cleaners Article on Sept. 18
09/16DJProspects for Economic Surge Ebb -- WSJ
09/16DJUnilever Is in Talks to Acquire Jessica Alba's Honest Co.
09/15 CLOROX CO /DE/ : Change in Directors or Principal Officers, Amendments to Articl..
09/15 CLOROX : Amy Banse Appointed to Clorox Board
More news
Sector news : Household Products - NEC
09/23DJINDIVIOR : Shares Plunge as More US States Join Lawsuit -- Update
09/23 INDIVIOR : U.S. states sue opioid-maker Indivior, alleging anticompetitive pract..
09/21DJRECKITT BENCKISER : Struggles to Move Past Disinfectant Deaths
09/21DJReckitt Benckiser Apologizes for Disinfectant Deaths
08/12DJALPHABET : Google Under Antitrust Scrutiny in South Korea
More sector news : Household Products - NEC
News from SeekingAlpha
09/20 Kellogg Has A Good Risk-Reward Ratio - Cramer's Lightning Round (9/19/16)
09/16 CLOROX : Cleaning Out The Competition
09/14 Clorox declares $0.80 dividend
09/10 A Dividend Growth Portfolio To Grow Old With
09/09 Clorox (CLX) Presents at Barclays Global Consumer Staples Conference Septembe..
Financials ($)
Sales 2017 5 962 M
EBIT 2017 1 126 M
Net income 2017 715 M
Debt 2017 1 770 M
Yield 2017 2,59%
P/E ratio 2017 23,08
P/E ratio 2018 21,90
EV / Sales 2017 3,03x
EV / Sales 2018 2,93x
Capitalization 16 306 M
More Financials
Duration : Period :
Clorox Co Technical Analysis Chart | CLX | US1890541097 | 4-Traders
Full-screen chart
Technical analysis trends CLOROX CO
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus HOLD
Number of Analysts 15
Average target price 128 $
Spread / Average Target 1,4%
Consensus details
EPS Revisions
More Estimates Revisions
Benno O. Dorer Chairman & Chief Executive Officer
Stephen M. Robb Chief Financial Officer & Executive Vice President
James E. Foster EVP-Information Technology & Product Supply
Robert W. Matschullat Lead Independent Director
Carolyn M. Ticknor Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CLOROX CO-0.78%16 286
CHURCH & DWIGHT CO., I..12.98%12 362
LION CORP40.27%4 588
More Results